An alternative view of heparin anticoagulation in acute focal brain ischemia.
- 1 February 1989
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 20 (2), 295-298
- https://doi.org/10.1161/01.str.20.2.295
Abstract
Despite the lack of evidence of its efficacy, heparin therapy has been recommended for selected patients with ischemic stroke syndromes. However, heparin has procoagulant effects on platelet function and a propensity to produce serious side effects. When these factors are considered, heparin loses its appeal as a therapeutic agent for patients with acute focal cerebral ischemia.Keywords
This publication has 31 references indexed in Scilit:
- Heparin Therapy for Recent Transient Focal Cerebral IschemiaMayo Clinic Proceedings, 1987
- Immune Endothelial-Cell Injury in Heparin-Associated ThrombocytopeniaNew England Journal of Medicine, 1987
- Pharmacology of heparin and warfarinJournal of the American College of Cardiology, 1986
- The heparin induced thrombosis — thrombocytopenia syndrome (H.I.T.T.S.): A reviewPathology, 1985
- Rationale Behind the Development of Low Molecular Weight Heparin DerivativesSeminars in Thrombosis and Hemostasis, 1985
- Heparin-lnduced Thrombocytopenia, Thrombosis, and HemorrhageAnnals of Surgery, 1983
- Immediate anticoagulation of embolic stroke: a randomized trial. Cerebral Embolism Study Group.Stroke, 1983
- Detection of a new heparin-dependent inhibitor of thrombin in human plasma.JCI Insight, 1981
- Heparin‐induced thrombocytopenia and recurrent thromboembolismAmerican Journal of Hematology, 1980
- Heparin Neutralization of PGI 2 : Effects Upon PlateletsScience, 1979